Cardinal Story

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;'>CH</div>
CAH -- USA Stock  

USD 52.97  0.22  0.42%

While this unique economic environment continues, Cardinal Health may throw investors more surprises next quarter. We will analyze why Cardinal Health investors may still consider a stake in the business. On the 5th of February the company is traded for 55.98. Cardinal Health has historical hype elasticity of 0.04. The average price elasticity to hype of competition is about 0.07. The entity is forecasted to increase in value after the next headline, with the price going to jump to 56.02. The average volatility of media hype impact on Cardinal Health stock price is about 140.16%. The price rise on the next news is estimated to be 0.07%, whereas the daily expected return is currently at 0.03%. The volatility of related hype on Cardinal Health is about 75.62% with expected price after next announcement by competition of 56.05 Considering the 30-day investment horizon the next forecasted press release will be in about 10 days.
Published over three weeks ago
View all stories for Cardinal Health | View All Stories
Will Cardinal Health continue to grow in March?
The company's average rating is Buy from 12 analysts. Our advice module provides unbiased investment recommendation that can be used to complement current average analyst sentiment on Cardinal Health. Our advice engine provides an advice for the firm potential to grow from the perspective of an investor's risk tolerance and investing horizon.
The successful prediction of Cardinal Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cardinal Health, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cardinal Health based on Cardinal Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cardinal Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cardinal Health's related companies.

Use Technical Analysis to project Cardinal expected Price

Cardinal Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cardinal Health technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cardinal Health trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Cardinal Health, but it might be worth checking our own buy vs. sell analysis

Sale by Jessica Mayer of 3500 shares of Cardinal Health

Legal trades by Cardinal Health insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Cardinal insider trading alert for sale of common shares by Jessica Mayer, Chief LegalCompliance Officer, on 1st of March 2021. This event was filed by Cardinal Health Inc with SEC on 2021-03-01. Statement of changes in beneficial ownership - SEC Form 4. Jessica Mayer currently serves as chief legal and compliance officer of Cardinal Health [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down the case for Cardinal Health

Cardinal Health reported the last year's revenue of 154.65 B. Total Income to common stockholders was 973 M with profit before taxes, overhead, and interest of 6.87 B.

Cost of Revenue Breakdown

Cardinal Health Cost of Revenue is increasing over the last several years with slightly volatile swings. Cost of Revenue is predicted to flatten to about 153 B. Cost of Revenue usually refers to the aggregate cost of goods produced and sold and services rendered during the reporting period. Cardinal Health Cost of Revenue is most likely to increase significantly in the upcoming years. The last year's value of Cost of Revenue was reported at 167.96 Billion
2014
2015
2016
2017
2018
2019
2020
2021
201496.82 Billion
2015115 Billion
2016123.43 Billion
2017129.63 Billion
2018138.7 Billion
2019146.05 Billion
2020167.96 Billion
2021153.03 Billion

Will Cardinal Health growth be feasible after the rise?

Current coefficient of variation is at 722.01. Cardinal Health has relatively low volatility with skewness of 0.39 and kurtosis of 2.49. However, we advise all investors to independently investigate Cardinal Health to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.

Our Conclusion on Cardinal Health

When is the right time to buy or sell Cardinal Health? Buying stocks such as Cardinal Health isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily basis. With an optimistic outlook on your 30 days horizon, it may be a good time to pick up new shares of Cardinal or increase your existing holdings in the Stock as it seems the potential growth has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Cardinal Health.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Cardinal Health. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com